Saanich-based pharmaceutical company stocks double in value after successful lupus drug trial

More than 40 per cent of patients using voclosporin saw improvements in kidney function

Saanich-based pharmaceutical company, Aurinia Pharmaceuticals, saw share values soar on Thursday after success with clinical trials for a new lupus drug.

On Dec. 4, the company announced that results from the AURORA Phase 3 drug trials for voclosporin had been successful in treating kidney inflammation in patients with lupus nephritis – an autoimmune disease.

Aurinia’s chief medical officer Neil Solomons explained that patients with lupus can experience “irreversible kidney damage” that can lead to kidney failure and death.

READ ALSO: Saanich biotech company secures $52M US for global drug study

The study included 357 patients from 27 countries living with lupus and the results showed that participants using voclosporin experienced a “renal response rate” of 40.8 per cent while just 22.5 per cent of participants in the control group – those who didn’t receive the drug – saw improvements.

Data also indicated that the group taking voclosporin saw no more adverse events than the group receiving standard lupus treatment, noted Brad Rovin, chief of the nephrology division at the Ohio State University Wexner Medical Centre.

Following the announcement of the drug’s successful Phase 3 trial, the company’s share price exploded on Thursday, rising from Wednesday’s close of $11.13 per share to touch a 52-week high of $23.04 before closing at $19.75. Its shares have risen from a 52-week low of $4.70 to close Friday at $20.48 – a gain of 336 per cent, driving the company’s market cap to $1.93 billion.

Lupus has historically been difficult to treat and new treatment options were needed, said Stevan Gibson, president and CEO of the Lupus Foundation of America. Voclosporin is the first effective therapeutic treatment option and the successful trial marks a step forward in treating the potentially deadly disease, he noted.

READ ALSO: Mental health call temporarily shuts down Trans Canada Highway in View Royal

Aurinia co-founder Mike Martin noted that after eight years of hard work, staff are excited about the outcomes of the trial. he emphasized that the drug’s success will be significant for people living with lupus – close to 1 million people worldwide.

“It was a pleasure to share the results,” Martin said. Given the data, he wasn’t surprised by the uptake in stock.

He emphasized how grateful the company is for the participants and for the opportunity to change the trajectory of people’s lives.

The company is planning to put the drug on the market as early as 2021, but first it must pass though the U.S. Food and Drug Administration (FDA) process. The drug was given a fast track by the FDA in 2016 and the company plans to submit to the FDA in early 2020.

With files from Paul Bucci.


@devonscarlett
Like us on Facebook and follow us on Twitter.

devon.bidal@saanichnews.com

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Royal Athletic Park will not be a shelter site during COVID-19 crisis: Victoria mayor

Indoor sites to be coordinated with Island Health, BC Housing

BC Ferries further reduces sailings in response to COVID-19

Any sailing reservations cancelled due to schedule changes will be refunded

COVID-19: Saanich company joins nation-wide effort to produce 30,000 ventilators

StarFish Medical using a ‘purpose-driven design for rapid manufacturing,’ CEO says

Judge rejects pandemic as reason to grant bail to immunocompromised prisoner

Esquimalt man told there are more health risks for addicts on the street than there are in jail

Canoe found in men’s public bathroom in Cadboro-Gyro Park

‘Please do not park your canoe in our bathrooms,’ say Saanich parks staff

UPDATE: Canadians awake to extra COVID-19 emergency benefit money, feds clarify changes

The CRA and federal officials are working to clarify the confusion around payments

B.C. sorting medical equipment sales, donation offers for COVID-19

Supply hub has call out for masks, gowns, coronavirus swabs

B.C. records five more deaths due to COVID-19, 45 new cases

A total of 838 people have recovered from the virus

Major crimes investigating sudden death of North Okanagan child

The 8 year old was flown to Kelowna General Hospital and died hours later

Easter Bunny added to B.C.’s list of essential workers

Premier John Horgan authorizes bunny to spread “eggs-ellent cheer” throughout province

Travellers returning to B.C. must have self-isolation plan or face quarantine: Horgan

Premier John Horgan says forms must be filled out by travellers

More than 400 animals have been adopted amid pandemic: B.C. SPCA

People are taking this time of social distancing to find a loyal companion through the animal welfare group

VIDEO: More than 85 people displaced by Campbell River apartment fire

Traffic is being diverted around Dogwood Street and 9th Avenue

Thieves steal $5,000 worth of cigarettes and candy from semi trailer in Nanaimo

Culprits hit truckload in shipping company storage yard on Old Victoria Road on Monday

Most Read